National Clinical Research - Richmond

Richmond, Virginia 23294

0 studies enrolling now · 12 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Chronic Weight Management, Congestive Heart Failure, Hyperlipidemia, Low Back Pain, Migraine, Non-Alcoholic Fatty Liver Disease, Overactive Bladder, Plaque Psoriasis

Studies at this site

• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — Running, not enrolling
• A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) — Completed
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early
• A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure — Completed